In any case, these studies show that the induction of ABC transporters such as P-gp may be a novel therapeutic strategy to protect the brain from Aβ accumulation, and thus, could impede the progression of neurologic diseases such as AD. This evidence concerns the gene ABCG2 and Alzheimer disease.